CompletedN/Aketamine

Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality

NCT ID

NCT04101474

Target Enrollment

36 participants

Start Date

2020-09-01

Est. Completion

2021-10-01

About This Study

In this study we will assess the effect of Ketamine infusion on depressive symptoms and in particular its effect on Suicidal behavior, ideation and thoughts in patients with treatment- resistant MDD.

Conditions Studied

Treatment Resistant Depression

Interventions

•Ketamine

Eligibility

Age:18 Years - N/A

Healthy Volunteers:No

View full eligibility criteria

Inclusion Criteria:

1. Patients fulfilling diagnostic criteria of treatment-resistant MDD.
2. Presence of suicidal risk.
3. No comorbid medical or neurological conditions.
4. Age above 18 years old.
5. Both gender.
6. Informed written consent from the patient or his legitimate.

Exclusion Criteria:

1. Presence of perceptual disturbance.
2. History of sensitivity to ketamine.
3. Refusal to participate in the study.

Study Locations (1)

Assiut university